Veda Giri, MD

Sidney Kimmel Cancer Center, Thomas Jefferson University

Veda N. Giri, MD is Professor in Medical Oncology, Cancer Biology, and Urology at Sidney Kimmel Cancer Center at Thomas Jefferson University. She is a medical oncologist with specialization in clinical cancer genetics. Dr. Giri is Director of Cancer Risk Assessment and Clinical Cancer Genetics at Thomas Jefferson University, where she leads an integrated and comprehensive effort in inherited cancer risk assessment and conducts studies focused on genetic evaluation of cancer risk. She has focused interest in developing the field of genetic counseling and genetic testing for inherited prostate cancer. Dr. Giri started the first Men’s Genetic Risk Clinic in the US in 2014 focused on genetic evaluation of inherited prostate cancer in the setting of multidisciplinary care. Dr. Giri also co-chaired the 2017 and 2019 Philadelphia Prostate Cancer Consensus Conferences that addressed development of comprehensive frameworks for genetic evaluation and implementation of genetic testing for prostate cancer. She is the Principal Investigator of multiple prostate cancer genetic evaluation studies addressing gaps in genetic counseling, genetic testing, disparities and equity in genetic testing, patient-reported outcomes,and implementation of genetic testing.

Disclosure information not submitted.

Presentation(s):

• Implementation of Germline Testing in Prostate Cancer

  Saturday, May 14, 2022
  3:25 PM – 3:35 PM